Obesidad visceral y riesgo de infarto de miocardio
DOI:
https://doi.org/10.56048/MQR20225.8.3.2024.501-519Palabras clave:
Obesidad Central; Obesidad abdominal; Obesidad Visceral; Infarto De Miocardio; Apoplejía cardiovascular; Ataques al corazónResumen
Introducción: La obesidad visceral, es considerada una patología de alto impacto en la enfermedad coronaria. El infarto agudo de miocardio se define patológicamente como la muerte de células miocárdicas debida a isquemia prolongada. Objetivo: evaluar la asociación entre obesidad visceral e infarto agudo de miocardio y su papel como identificador de riesgo. Materiales y métodos: se realizó una revisión bibliográfica de la literatura, de artículos de los últimos 5 años, en los idiomas español e inglés, obtenidos de bases de datos reconocidas. Discusión: La obesidad central aumenta el riesgo de IAM y tienen una repercusión directa sobre la morbimortalidad en pacientes con desarrollo de mayores eventos adversos cardiovasculares. Conclusión: La obesidad central, es el mejor indicador de riesgo cardiovascular antropométrico, para desarrollar eventos cardiovasculares adversos, por lo que, su prevención podría ayudar a disminuir las tasas de infarto en las próximas décadas.
Descargas
Métricas
Cited
DOI: 10.56048
Citas
- Raheem J, Sliz E, Shin J, Holmes MV, Pike GB, Richer L, Gaudet D, Paus T, Pausova Z. Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction. Commun Med (Lond). 2022 Jul 1;2:81. doi: 10.1038/s43856-022-00140-5.
- Frühbeck G, Gómez-Ambrosi J. Adipose tissue: structure, function and metabolism. En: Reference Module in Food Science [Internet]. Elsevier; 2022 [citado 22 de junio de 2022]. Disponible en: https://www.sciencedirect.com/science/article/pii/B9780128218488000640.
- Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 3 de febrero de 2022;185(3):419-46.
- Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Bernard R Chaitman, Jeroen J Bax, David A Morrow, Harvey D White, ESC Scientific Document Group, Fourth universal definition of myocardial infarction (2018), European Heart Journal, Volume 40, Issue 3, 14 January 2019, Pages 237–269, https://doi.org/10.1093/eurheartj/ehy462
- Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Piero Perna G, Riezebos RK, McFalls EO, Banerjee S, Bagai A, Gosselin G, O'Brien SM, Rockhold FW, Waters DD, Thygesen KA, Stone GW, White HD, Maron DJ, Hochman JS; ISCHEMIA Research Group. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation. 2021 Feb 23;143(8):790-804. doi: 10.1161/CIRCULATIONAHA.120.047987.
- Organización Mundial de la Salud. 2021. Obesidad y sobrepeso. Recuperado de: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
- Sucato V, Coppola G, Manno G, Vadalà G, Novo G, Corrado E, Galassi AR. Coronary Artery Disease in South Asian Patients: Cardiovascular Risk Factors, Pathogenesis and Treatments. Curr Probl Cardiol. 2022 Apr 29:101228. https://doi.org/10.1016/j.cpcardiol.2022.101228.
- Martín Castellanos Á, Martín Castellanos P, Martín E, Barca Durán FJ. Abdominal obesity and myocardial infarction risk - We demonstrate the anthropometric and mathematical reasons that justify the association bias of the waist-to-hip ratio. Nutr Hosp. 2021 Jun 10;38(3):502-510. doi: 10.20960/nh.03416.
- Martín Castellanos Á, Cabañas Armesilla MD, Barca Durán FJ, Martín Castellanos P, Gómez Barrado JJ. Obesidad y riesgo de infarto de miocardio en una muestra de varones europeos. El índice cintura-cadera sesga el riesgo real de la obesidad abdominal. Nutr Hosp. 1 de febrero de 2017;34(1):88.
- Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, Harrap S, Woodward M. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study. Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311.
- Lange M, Angelidou G, Ni Z, Criscuolo A, Schiller J, Blüher M, Fedorova M. AdipoAtlas: A reference lipidome for human white adipose tissue. Cell Rep Med. 2021 Sep 22;2(10):100407. doi: 10.1016/j.xcrm.2021.100407.
Korhonen PE, Mikkola T, Kautiainen H, Eriksson JG. Both lean and fat body mass associate with blood pressure. European Journal of Internal Medicine. 1 de septiembre de 2021;91:40-4.
- Tiffany M. Wiley P, Poirier P. et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. CirculationVolume 143, Issue 21, 25 May 2021; Pages e984-e1010. https://doi.org/10.1161/CIR.0000000000000973.
- Zhao L, Hutchison AT, Liu B, Yates CL, Teong XT, Wittert GA, et al. Time-restricted eating improves glycemic control and dampens energy-consuming pathways in human adipose tissue. Nutrition. 1 de abril de 2022;96:111583.
- Maximus PS, Al Achkar Z, Hamid PF, Hasnain SS, Peralta CA. Adipocytokines: Are they the Theory of Everything? Cytokine. 1 de septiembre de 2020;133:155144.
- Huang Y, Liu Y, Ma Y, Tu T, Liu N, Bai F, Xiao Y, Liu C, Hu Z, Lin Q, Li M, Ning Z, Zhou Y, Mao X, Liu Q. Associations of Visceral Adipose Tissue, Circulating Protein Biomarkers, and Risk of Cardiovascular Diseases: A Mendelian Randomization Analysis. Front Cell Dev Biol. 2022 Feb 3;10:840866. doi: 10.3389/fcell.2022.840866.
Paiman EHM, de Mutsert R, Widya RL, Rosendaal FR, Jukema JW, Lamb HJ. The role of insulin resistance in the relation of visceral, abdominal subcutaneous and total body fat to cardiovascular function. Nutrition, Metabolism and Cardiovascular Diseases. 27 de noviembre de 2020;30(12):2230-41.
Takahari K, Utsunomiya H, Itakura K, Yamamoto H, Nakano Y. Impact of the distribution of epicardial and visceral adipose tissue on left ventricular diastolic function. Heart Vessels. 1 de febrero de 2022;37(2):250-61.
- Su X, Chang D. Role of adiposopathy and physical activity in cardio-metabolic disorder diseases. Clinica Chimica Acta. 1 de diciembre de 2020;511:243-7.
- Cao Q, Yu S, Xiong W, Li Y, Li H, Li J, Li F. Waist-hip ratio as a predictor of myocardial infarction risk: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Jul;97(30):e11639. doi: 10.1097/MD.0000000000011639.
- Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Matveeva V, Karetnikova V, Kokov A, Barbarash O. Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity. BMC Cardiovasc Disord. 2017 Jan 19;17(1):36. https://doi.org/10.1186/s12872-017-0473-x.
- Mohammadi H, Ohm J, Discacciati A, Sundstrom J, Hambraeus K, Jernberg T, Svensson P. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol. 2020 Dec;27(18):1944-1952. doi: 10.1177/2047487319898019.
- Corina-Sosa Betsy, Basurto Lourdes, Luqueño Eva, Robledo Ariadna, Mendieta-Zerón Hugo, Oros-Pantoja Rigoberto. Los colores del tejido adiposo y la relación con la irisina. Cir. cir. [revista en la Internet]. 2020 Oct [citado 2023 Ene 31] ; 88( 5 ): 664-671. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2444-054X2020000500664&lng=es. Epub 08-Nov-2021. https://doi.org/10.24875/ciru.20000057.
- Segiet OA, Piecuch A, Mielanczyk L, Michalski M, Nowalany-Kozielska E. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 2019 Nov;22(6):287-299. doi: 10.14744/AnatolJCardiol.2019.32748.
- Mohammadi H, Ohm J, Discacciati A, Sundstrom J, Hambraeus K, Jernberg T, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. European Journal of Preventive Cardiology. 1 de diciembre de 2020;27(18):1944-52.
- Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176.
- Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study. The American Journal of Medicine. 1 de junio de 2018;131(6):684-692.e12.
- Cho DH, Kim MN, Joo HJ, Shim WJ, Lim DS, Park SM. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases. abril de 2019;29(4):360-6.
- Gutiérrez YM, Rodríguez LB, Rojas LRL, Torres YO, González AM, González CBC. Relationship among the epicardial fat volume and Coronary Artery Disease in patients with indication of coronary angiogram by multislices computed tomography. Rev Cubana Cardiol Cir Cardiovasc [Internet]. 2019 [citado 23 de junio de 2022];25(1). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=85711.
- Villasante Fricke AC, Iacobellis G. Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk. International Journal of Molecular Sciences. enero de 2019;20(23):5989.
- Sánchez E, Sánchez M, López-Cano C, Bermúdez-López M, Valdivielso JM, Farràs-Sallés C, Pamplona R, Torres G, Mauricio D, Castro E, Fernández E, Lecube A. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project. Nutrients. 2023; 15(1):203. https://doi.org/10.3390/nu15010203.
- Hussid MF, Cepeda FX, Jordão CP, Lopes-Vicente RRP, Virmondes L, Katayama KY, et al. Visceral Obesity and High Systolic Blood Pressure as the Substrate of Endothelial Dysfunction in Obese Adolescents. Arq Bras Cardiol. abril de 2021;116(4):795-803.
- Carbone A, Al Salhi Y, Tasca A, Palleschi G, Fuschi A, De Nunzio C, Bozzini G, Mazzaferro S, Pastore AL. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018 Aug;70(4):393-400. doi: 10.23736/S0393-2249.18.03113-2.
- Migueles, J. H., Cadenas-Sanchez, C., Lubans, D. R., Henriksson, P., Torres-Lopez, L. V., Rodriguez-Ayllon, M., Plaza-Florido, A., Gil-Cosano, J. J., Henriksson, H., Escolano-Margarit, M. V., Gómez-Vida, J., Maldonado, J., Löf, M., Ruiz, J. R., Labayen, I., & Ortega, F. B. (2023). Effects of an Exercise Program on Cardiometabolic and Mental Health in Children With Overweight or Obesity: A Secondary Analysis of a Randomized Clinical Trial. JAMA network open, 6(7), e2324839. https://doi.org/10.1001/jamanetworkopen.2023.24839
Silver, H. J., Olson, D., Mayfield, D., Wright, P., Nian, H., Mashayekhi, M., Koethe, J. R., Niswender, K. D., Luther, J. M., & Brown, N. J. (2023). Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes. Diabetes, obesity & metabolism, 25(8), 2340–2350. https://doi.org/10.1111/dom.15113
-Rossing, P., Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., Ahlers, C., Lage, A., Lawatscheck, R., Scalise, A., & Bakris, G. L. (2023). The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study. Diabetes, obesity & metabolism, 25(10), 2989–2998. https://doi.org/10.1111/dom.15197
- Dokpuang, D., Zhiyong Yang, J., Nemati, R., He, K., Plank, L. D., Murphy, R., & Lu, J. (2023). Magnetic resonance study of visceral, subcutaneous, liver and pancreas fat changes after 12 weeks intermittent fasting in obese participants with prediabetes. Diabetes research and clinical practice, 202, 110775. https://doi.org/10.1016/j.diabres.2023.110775
- Koschker, A. C., Warrings, B., Morbach, C., Seyfried, F., Jung, P., Dischinger, U., Edelmann, F., Herrmann, M. J., Stier, C., Frantz, S., Malzahn, U., Störk, S., Fassnacht, M., & WAS study group (2023). Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial. Metabolism: clinical and experimental, 147, 155655. https://doi.org/10.1016/j.metabol.2023.155655
- Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., Ryan, D. H., & SELECT Trial Investigators (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England journal of medicine, 389(24), 2221–2232. https://doi.org/10.1056/NEJMoa2307563
- Kim, H. T., Jung, S. Y., Nam, J. H., Lee, J. H., Lee, C. H., Son, J. W., Kim, U., Park, J. S., Shin, D. G., Her, S. H., Chang, K. Y., Ahn, T. H., Jeong, M. H., Rha, S. W., Kim, H. S., Gwon, H. C., Seong, I. W., Hwang, K. K., Chae, S. C., Kim, K. B., … KAMIR-NIH registry investigators (2021). Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial Infarction. Heart, lung & circulation, 30(4), 481–488. https://doi.org/10.1016/j.hlc.2020.08.013
- Hidvegi, R., Puelacher, C., Gualandro, D. M., Lampart, A., Lurati Buse, G., Hammerer-Lerchner, A., Walter, J., Liffert, M., Bolliger, D., Steiner, L., Kindler, C., Espinola, J., Strebel, I., Gueckel, J., Marbot, S., Arslani, K., Boeddinghaus, J., Nestelberger, T., Zimmermann, T., Freese, M., … BASEL-P.M.I. Investigators (2020). Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery. Clinical research in cardiology : official journal of the German Cardiac Society, 109(9), 1140–1147. https://doi.org/10.1007/s00392-020-01605-0
- Gualandro, D. M., Puelacher, C., Lurati Buse, G., Glarner, N., Cardozo, F. A., Vogt, R., Hidvegi, R., Strunz, C., Bolliger, D., Gueckel, J., Yu, P. C., Liffert, M., Arslani, K., Prepoudis, A., Calderaro, D., Hammerer-Lercher, A., Lampart, A., Steiner, L. A., Schären, S., Kindler, C., … BASEL-PMI Investigators (2021). Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I. Clinical research in cardiology : official journal of the German Cardiac Society, 110(9), 1450–1463. https://doi.org/10.1007/s00392-021-01827-w
- Kim, W. J., Lim, H. J., Moon, J. Y., Kim, S. H., Sung, J. H., Kim, I. J., Lim, S. W., Cha, D. H., & Kang, S. H. (2024). Sex differences in the impact of body mass index on outcomes of coronary artery disease in Koreans. Coronary artery disease, 35(3), 193–200. https://doi.org/10.1097/MCA.0000000000001346
- Formentini, F. S., Zaina Nagano, F. E., Lopes Neto, F. D. N., Adam, E. L., Fortes, F. S., & Silva, L. F. D. (2019). Coronary artery disease and body mass index: What is the relationship?. Clinical nutrition ESPEN, 34, 87–93. https://doi.org/10.1016/j.clnesp.2019.08.008
- Formentini, F. S., Zaina Nagano, F. E., Lopes Neto, F. D. N., Adam, E. L., Fortes, F. S., & Silva, L. F. D. (2019). Coronary artery disease and body mass index: What is the relationship?. Clinical nutrition ESPEN, 34, 87–93. https://doi.org/10.1016/j.clnesp.2019.08.008
- Rao, C., Zhong, Q., Wu, R., Li, Z., Duan, Y., Zhou, Y., Wang, C., Chen, X., Wang, R., & He, K. (2024). Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study. BMC cardiovascular disorders, 24(1), 113. https://doi.org/10.1186/s12872-024-03770-w
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
®
Los autores se comprometen a respetar la información académica de otros autores, y a ceder los derechos de autor a la Revista MQRInvestigar, para que el artículo pueda ser editado, publicado y distribuido. El contenido de los artículos científicos y de las publicaciones que aparecen en la revista es responsabilidad exclusiva de sus autores. La distribución de los artículos publicados se realiza bajo una licencia 
